Kaplan-Meier curves were performed to compare the RFS outcome between the high- and low-risk patients determined by the miRNA-based signature. The ROC curve was plotted with the R package “pROC”. The predictive value was assessed by the area under the ROC curve (AUC). In addition, nomogram ROC analysis was used to synthesize the miRNA-based signature with the clinicopathological features, as well as the laboratory test results. In addition, the Kaplan-Meier plot and log-rank analyses were used to determine the survival difference between high- and low-risk subgroups, and the univariate Cox analysis was used to generate the hazed ratio (HR) and 95% confidential interval (95% CI) among high- and low-risk subgroups.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.